CollaGenex Pharmaceuticals Appoints George Lasezkay to its Board of Directors

26-Sep-2005

CollaGenex Pharmaceuticals, Inc. announced the appointment of George Lasezkay, Pharm.D., J.D., to its Board of Directors. Dr. Lasezkay will also serve on the Board's audit committee.

Dr. Lasezkay has an extensive background in the pharmaceutical industry, including 13 years experience with Allergan, Inc., a specialty pharmaceutical company focusing on ophthalmology and dermatology, where he was Corporate Vice President, Corporate Development, and, before that, its Assistant General Counsel. He currently serves on the Board of Directors of Acuity Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Novagali Pharma S.A. and Valentis Inc., and he is a former member of the Board of ISTA Pharmaceuticals, Inc. Dr. Lasezkay provides business development and strategic advisory services to emerging pharmaceutical and biotechnology companies as a Principal at Turning Point Consultants, LLC.

Other news from the department people

These products might interest you

Milli-Q® Services / MyMilli-Q™

Milli-Q® Services / MyMilli-Q™ by Merck Life Science

Services & Support for Water Purification Systems

Quality Care, Delivered. In Person & Online

water treatment systems
Good Weighing Practice

Good Weighing Practice by Mettler-Toledo

Your Concrete Weighing Quality Assurance Plan

GWP Verification service

services
Loading...

More news from our other portals

All FT-IR spectrometer manufacturers at a glance